First Canadian clinical trials for COVID-19 vaccine to be led by Dalhousie University researchers
With several potential vaccines for COVID-19 being researched across Canada, the first to enter clinical (human) trials will happen at the Canadian Centre for Vaccinology, located at Dalhousie University in Halifax, N.S. The team there is building on research conducted by its Chinese partner CanSino Biologics, which is already conducting clinical trials in China.
The first phases of testing will begin within a few weeks and will closely monitor both younger and older adults to see how well their bodies tolerate the prospective vaccine. Once those trials are complete, the next testing phase will determine the effectiveness of the vaccine at preventing COVID-19 infection.
Generally, the process of creating vaccines takes years, but the Canadian government might permit a vaccine that has been shown to be safe and effective to be released early, due to the emergency nature of the COVID-19 pandemic. If it does work, the National Research Council will help the vaccine’s makers to produce and distribute it here in Canada.
Source: Dalhousie University